These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 19303308

  • 1. Molecular modeling studies and in vitro bioactivity evaluation of a set of novel 5-nitro-heterocyclic derivatives as anti-T. cruzi agents.
    Paula FR, Jorge SD, de Almeida LV, Pasqualoto KF, Tavares LC.
    Bioorg Med Chem; 2009 Apr 01; 17(7):2673-9. PubMed ID: 19303308
    [Abstract] [Full Text] [Related]

  • 2. 5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.
    Cabrera E, Murguiondo MG, Arias MG, Arredondo C, Pintos C, Aguirre G, Fernández M, Basmadjián Y, Rosa R, Pacheco JP, Raymondo S, Di Maio R, González M, Cerecetto H.
    Eur J Med Chem; 2009 Oct 01; 44(10):3909-14. PubMed ID: 19446929
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of the trypanocidal activity of the methyl 1-nitrophenyl-1,2,3,4-9H-tetrahydro-beta-carboline-3-carboxylate derivatives and benznidazole using theoretical calculations and cyclic voltammetry.
    Tonin LT, Barbosa VA, Bocca CC, Ramos ER, Nakamura CV, da Costa WF, Basso EA, Nakamura TU, Sarragiotto MH.
    Eur J Med Chem; 2009 Apr 01; 44(4):1745-50. PubMed ID: 18504061
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Design, synthesis, antimicrobial activity and molecular modeling studies of novel benzofuroxan derivatives against Staphylococcus aureus.
    Jorge SD, Masunari A, Rangel-Yagui CO, Pasqualoto KF, Tavares LC.
    Bioorg Med Chem; 2009 Apr 15; 17(8):3028-36. PubMed ID: 19324556
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Imidazolidines as new anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
    Caterina MC, Perillo IA, Boiani L, Pezaroglo H, Cerecetto H, González M, Salerno A.
    Bioorg Med Chem; 2008 Mar 01; 16(5):2226-34. PubMed ID: 18083035
    [Abstract] [Full Text] [Related]

  • 11. Second generation of 5-ethenylbenzofuroxan derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and structure-activity relationships.
    Porcal W, Hernández P, Aguirre G, Boiani L, Boiani M, Merlino A, Ferreira A, Maio RD, Castro A, González M, Cerecetto H.
    Bioorg Med Chem; 2007 Apr 01; 15(7):2768-81. PubMed ID: 17287123
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis and in vitro antitrypanosomal activity of novel Nifurtimox analogues.
    Pozas R, Carballo J, Castro C, Rubio J.
    Bioorg Med Chem Lett; 2005 Mar 01; 15(5):1417-21. PubMed ID: 15713399
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.